ExoVectory selected for the NL-USA Health Accelerator Program

We’re excited to announce that ExoVectory has been selected for the NL-USA Health Accelerator Program. Our CEO Jeroen de Vrij will join this six-week program focused on preparing ExoVectory for US market entry — starting in Rotterdam and culminating in a one-week business trip to Cedars-Sinai Accelerator+ in Los Angeles this November.

The program comes at a great time for ExoVectory as we advance our ExoVec delivery platform and prepare for the next stage of growth.

Preparing for our next stage of growth

Key objectives include:

• Strengthening our research programs and connections with US key opinion leaders.
• Exploring partnerships with the Cedars-Sinai Biomanufacturing Center.
• Preparing for our next stage of investment and business development.

We’re looking forward to an exciting six weeks and will share our progress along the way!

Learn more about our ExoVec delivery platform or contact our team about partnerships and investment opportunities.

Read the original announcement on LinkedIn.

Explore our exosome delivery technology or contact ExoVectory about partnerships and investment.